Showing results (511-520 of 527) with videos related to
Sort By:
Pageof 53
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 6, 2023
Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancerTomohiro Miyoshi, Hiroyuki Ito, Masashi Wakabayashi, et al.JTCVS Open|May 4, 2026
Induction chemotherapy plus bevacizumab or radiotherapy in N2 non-squamous non-small cell lung cancer: 5-year results of a randomized phase 2 trialKazuya Takamochi, Kenji Suzuki, Masahiro Tsuboi, et al.The Lancet. Oncology|April 13, 2019
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trialHaruhiro Saito, Tatsuro Fukuhara, Naoki Furuya, et al.The Lancet. Respiratory Medicine|March 9, 2023
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialKeiju Aokage, Kenji Suzuki, Hisashi Saji, et al.The Lancet. Respiratory Medicine|August 29, 2021
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trialYosuke Kawashima, Tatsuro Fukuhara, Haruhiro Saito, et al.JAMA Oncology|December 21, 2023
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical TrialYoshimasa Shiraishi, Junji Kishimoto, Shunichi Sugawara, et al.The Journal of Thoracic and Cardiovascular Surgery|November 27, 2009
Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysisEric Lim, Rachel Clough, Peter Goldstraw, et al.Respiratory Research|July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.Cancer Science|May 15, 2023
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407Shunichi Sugawara, Kentaro Tanaka, Fumio Imamura, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 12, 2026
Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607LShinya Katsumata, Atsushi Kamigaichi, Takaki Akamine, et al.Pageof 53